Narrowband ultraviolet B for the treatment of vitiligo

Expert Review of Dermatology

Volumn 5, Issue 4, 2010, Pages 445-459

  Parsad, Davinder ^a   Bhatnagar, Abha ^b   De, Dipankar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b Chaitanya Hospital   (India)

Author keywords

combination therapies; comparison; dosimetry; evolution; future prospects; mechanism of action; monotherapy; NBUVB; PUVA

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CALCIPOTRIOL; CALCITRIOL; PIMECROLIMUS; PLACEBO; POLYPODIUM LEUCOTOMOS EXTRACT; PROSTAGLANDIN E2; PROSTAGLANDIN F2; PSEUDOCATALASE MOUSSE; PSORALEN; TACALCITOL; TACROLIMUS; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; AUTOIMMUNITY; CANCER RISK; CLINICAL EFFECTIVENESS; DOSIMETRY; ERYTHEMA; EXCIMER LASER; HUMAN; IMMUNOMODULATION; MONOCHROMATIC EXCIMER LIGHT; MONOTHERAPY; NARROWBAND ULTRAVIOLET B; NONHUMAN; PHOTOTHERAPY; PHOTOTOXICITY; PIGMENTATION; PRIORITY JOURNAL; PRURITUS; PUVA; QUALITY OF LIFE; REVIEW; SAFETY; SIDE EFFECT; SKIN BURNING SENSATION; SKIN TUMOR; TREATMENT RESPONSE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VASODILATATION; VITILIGO; XEROSIS;

EID: 77955238857     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/edm.10.34     Document Type: Review

References (65)

1. Morrison WL, Hann SK, Norlund JJ. PUVA Therapy in Vitiligo. Panther Publishers Ltd, Bangalore, India, 168-172 (2000).
2. El Mofty AM. A preliminary clinical report on the treatment of leucoderma with Ammi majus Linn. J. Eygpt Med. Assoc. 31, 651-665 (1948).
3. Fischer T. Comparative treatment of psoriasis with UV-light, trioxsalen plus UV-light and coal tar plus UV-light. Acta Derm. Venereol. 57, 345-350 (1977).
4. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J. Invest. Dermatol. 76, 359-362 (1981).
5. Van Weelden H, Baart de la Faille H, Young E, van der Leun JC. A new development in UVB phototherapy for psoriasis. Br. J. Dermatol. 119, 11-19 (1988).
6. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phtotherapy-an effective treatment for psoriasis. Br. J. Dermatol. 119, 691-696 (1988).
7. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B vs topical psoralen plus UV-A. Arch. Dermatol. 133, 1525-1528 (1997).
8. Norris DA, Horikawa T, Morelli JG. Melanocyte destruction and repopulation in vitiligo. Pigment Cell Res. 7, 193-203 (1994).
9. Cui J, Shen LY, Wang GC. Role of hair follicles in the repigmentation of vitiligo. J. Invest. Dermatol. 97, 410-416 (1991).
10. Englaro W, Bahadoan P, Bertolotto C et al. Tumor necrosis factor-a mediated inhibition of melanogenesis is dependent on nuclear factor k B activation. Oncogene 18, 1553-1559 (1999)
11. Swope VB, Sauder DN, McKenzie RC et al. Synthesis of interleukin-1a and 1b by normal human melanocytes. J. Invest. Dermatol. 102, 749-753 (1994).
12. Imokawa G, Miyagishi M, Yada Y. Endothelin 1 as a new melanogen: coordinated exposure of its gene and the tyrosinase gene in UVB exposed human epidermis. J. Invest. Dermatol. 105, 32-37 (1995).
13. Pentland A, Mahoney M. Keratinocyte prostaglandin synthesis is enhanced by IL-1. J. Invest. Dermatol. 94, 43-46 (1990).
14. Parsad D, Pandhi R, Dogra S, Pandhi R. Topical prostaglandin analogue (PGE2) in vitiligo-a preliminary study. Int. J. Dermatol. 41, 942-945 (2002).
15. Gordon PM, Diffey BL, Matthews JN. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J. Am. Acad. Dermatol. 41, 728-732 (1999).
16. Ibbotson SH, Bilsland D, Cox NH et al. An update and guidance on narrowband ultraviolet B phototherapy: a British Photodermatology Group Workshop report. Br. J. Dermatol. 151, 283-297 (2004).
17. Jo SJ, Yoon HS, Woo SM, Youn JI. Time course of tanning induced by narrow-band UVB phototherapy in Korean psoriasis patients. Photodermatol. Photoimmunol. Photomed. 22, 193-199 (2006).
18. Kunisada M, Kumimoto H, Ishizaki K, Sakumi K, Nakabeppu Y, Nishigori C. Narrow-band UVB induces more carcinogenic skin tumors than broad-band UVB through the formation of cyclobutane pyrimidine dimer. J. Invest. Dermatol. 127, 2865-2871 (2007).
19. Man I, Crombie IK, Dawe RS. The photocarcinogenic risk of narrowband TL-01 ultraviolet B therapy: early follow up data. Br. J. Dermatol. 152, 755-757 (2005).
20. Seo SL, Kim IH. Squamous cell carcinoma in a patient with generalized vitiligo. J. Am. Acad. Dermatol. 45, S227-S229 (2001).
21. Njoo MD, Westerhof W, Bos JD. The development of guidelines for treatment of vitiligo. Arch. Dermatol. 135, 1514-1521 (1999).
22. Gawkrodger DJ, Ormerod AD, Shaw L et al. Guideline for the diagnosis and management of vitiligo. Br. J. Dermatol. 159, 1051-1076 (2008).
23. Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy. Int. J. Dermatol. 44, 57-60 (2005).
24. Brazzelli V, Antoninetti M, Palazzini S, Barbagallo T, De Silvestri A, Borroni G. Critical evaluation of the variants infuencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy. J. Eur. Acad. Dermatol. Venereol. 21, 1369-1374 (2007).
25. Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the vitiligo area scoring system. Arch. Dermatol. 140, 677-683 (2004).
26. Kishan Kumar YH, Rao GR, Gopal KV, Shanti G, Rao K V. Evaluation of narrowband UVB phototherapy in 150 patients with vitiligo. Indian J. Dermatol. Venereol. Leprol. 75, 162-166 (2009).
27. Parsad D, Kanwar AJ, Kumar B. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 175-177 (2006).
28. Yones SS, Palmer RA, Garibaldinos TM, Hawk JL. Randomized double-blind trial of treatment of vitiligo. Arch. Dermatol. 143, 578-584 (2007).
29. El Mofty M, Mostafa W, Esmat S. Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies. Photodermatol. Photoimmunol. Photomed. 22, 6-11 (2006).
30. Bhatnagar A, Kanwar AJ, Parsad D, De D. Comparison of systemic PUVA and NBUVB in the treatment of vitiligo: an open prospective study. J. Eur. Acad. Dermatol. Venereol. 21, 638-642 (2007).
31. Scherschun L, Kim JJ, Lim HW. Narrowband ultraviolet B is a useful and well-tolerated treatment for vitiligo. J. Am. Acad. Dermatol. 44, 999-1003 (2001).
32. Bhatnagar A, Kanwar AJ, Parsad D, De D. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J. Eur. Acad. Dermatol. Venereol. 21, 1381-1385 (2007).
33. Jaisankar TJ, Baruah MC, Garg BR. Vitiligo in children. Int. J. Dermatol. 31, 621-623 (1992).
34. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J. Am. Acad. Dermatol. 42, 245-253 (2000).
35. Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin. Exp. Dermatol. 30, 332-336 (2005).
36. Novak Z, Bonis B, Baltas E et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J. Photochem. Photobiol. B 67, 32-38 (2002).
37. Casacci M, Thomas P, Pacifco A, Bonnevalle A, Paro Vadolin A, Leone G. Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo-a multicentre controlled study. J. Eur. Acad. Dermatol. Venereol. 21, 956-963 (2007).
38. Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled trial. J. Eur. Acad. Dermatol. Venereol. 21, 942-950 (2007).
39. Del'Anna ML, Mastrofrancesco A, Sala R et al. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin. Exp. Dermatol. 32, 631-636 (2007).
40. Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J. Clin. Pharmacol. 49, 852-855 (2009).
41. Bakis-Petsoglou S, Le Guay JL, Wittal R. A randomized double-blinded, placebo controlled trial of pseudocatalase cream and narrowband ultraviolet B in treatment of vitiligo. Br. J. Dermatol. 161, 910-917 (2009).
42. Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and NBUVB phototherapy is not effective for vitiligo: an open single-center study. Clin. Exp. Dermatol. 27, 641-644 (2002).
43. Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch. Dermatol. 139, 393 (2003).
44. Goktas EO. Aydin F, Senturk N, Canturk MT, Turanli AY. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo. J. Eur. Acad. Dermatol. Venereol. 20, 553-557 (2006).
45. Kullavanijaya P, Lim HW. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol. Photimmunol. Photomed. 20, 248-250 (2004).
46. Arca E, Tastan HB, Erbil AH, Sezer E, Koc E, Kurumlu Z. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J. Dermatol. 33, 338-343 (2006).
47. Hartmann A, Lurz C, Hamm H, Brocker E-B, Hofmann UB. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs placebo in vitiligo. Int. J. Dermatol. 44, 736-742 (2005).
48. Leone G, Pacifco A, Lacovelli P, Paro Vidolin A, Picardo M. Tacacitol and narrow-band phototherapy in patients with vitiligo. Clin. Exp. Dermatol. 31, 200-205 (2006).
49. Katayama I, Ashida M, Maeda A, Eishi K, Murota H, Bae SJ. Open trial of topical tacalcitol and solar irradiation for vitiligo vulgaris: upregulation of c-Kit mRNA by cultured melanocytes. Eur. J. Dermatol. 13, 372-376 (2003).
50. De Haes P, Garmyn M, Verstuyf A et al. 1,25-dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J. Photochem. Photobiol. B 78, 141-148 (2005).
51. Ellison TI, Smith MK, Gilliam AC, MacDonald PN. Inactivation of the vitamin D receptor enhances susceptibility of murine skin to UV-induced tumorigenesis. J. Invest. Dermatol. 128, 2508-2517 (2008).
52. Ongenae K, Dierckxsens L, Brochez L, vanGeel N, Naeyaert JM. Quality of life and stigmatization profle in a cohort of vitiligo patients and effect of the use of camofauge. Dermatology 210, 279-285 (2005).
53. Mayoral FA, Gonzalez C, Shah NS, Arcinigas C. Repigmentation of vitligo with pimecrolimus cream: a case report. Dermatology 207, 322-323 (2003).
54. Mehrabi D, Pandya AG. A randomized placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.01% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. Arch. Dermatol. 142, 927-929 (2006).
55. Fai D, Cassano N, Vena GA. Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients. J. Eur. Acad. Dermatol. Venereol. 21, 916-920 (2007).
56. Esfandiarpour I, Ekhlasi A, Farajzadeh S, Shamsadini S. The effcacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo controlled clinical trial. J. Dermatol. Treat. 20, 14-18 (2009).
57. El Mofty M, Zaher H, Esmat S et al. PUVA and PUVB in vitiligo: are they equally effective? Photodermatol. Photoimmunol. Photomed. 17, 159-163 (2001).
58. Anbar TS, El-Ammawi TS, Barakat M, Fawzy A. Skin pigmentation after NB-UVB and three analogues of PGF2a in guinea pigs: a comparative study. J. Eur. Acad. Dermatol. Venereol. 24, 28-31 (2010).
59. Nicolaidou E, Antoniou C, Stratigos AJ, Stefanaki C, Katsambas AD. Effcacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy. J. Am. Acad. Dermatol. 56, 274-278 (2007).
60. Chen GY, Hsu MM, Tai HK et al. Narrow-band UVB treatment of vitiligo in Chinese. J. Dermatol. 32, 793-800 (2005).
61. Njoo MD, Spuls PI, Bos JD et al. Nonsurgical repigmentation therapies in vitiligo: metaanalysis of the literature. Arch. Dermatol. 134, 1532-1540 (1998).
62. Anbar TS, Westerhof W, Abdel-Rahman AT, El-Khayyat MA. Evaluation of the effects of NB-UVB in both segmental and non-segmental vitiligo affecting different body sites. Photodermaol. Photoimmunol. Photmed. 22, 157-163 (2006).
63. Sitek JC, Loeb M, Ronnevig JR. Narrowband UVB therapy for vitiligo: does the repigmentation last? J. Eur. Acad. Dermatol. Venereol. 21, 891-896 (2007).
64. Tjioe M, Otero ME, van de Kerkhof PC, Gerritsen MJ. Quality of life in vitiligo patients after treatment with long-term narrowband ultraviolet B phototherapy. J. Eur. Acad. Dermatol. Venereol. 19, 56-60 (2005).
65. Taieb A, Picardo M. The defnition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35 (2007).